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Abstract Given the concurrent, escalating epidemic of
diabetes mellitus and neurodegenerative diseases, two
age-related disorders, we aimed to understand the rela-
tion between parameters of glucose metabolism and
indices of pathology in the aging brain. From the
Leiden Longevity Study, 132 participants (mean age
66 years) underwent a 2-h oral glucose tolerance test
to assess glucose tolerance (fasted and area under the
curve (AUC) glucose), insulin sensitivity (fasted and
AUC insulin and homeostatic model assessment of in-
sulin sensitivity (HOMA-IS)) and insulin secretion
(insulinogenic index). 3-T brain MRI was used to detect
macro-structural damage (atrophy, white matter hyper-
intensities, infarcts and/or micro-bleeds) and magnetiza-
tion transfer imaging (MTI) to detect loss of micro-
structural homogeneity that remains otherwise invisible
on conventional MRI. Macro-structurally, higher fasted
glucose was significantly associated with white matter
atrophy (P = 0.028). Micro-structurally, decreased mag-
netization transfer ratio (MTR) peak height in gray
matter was associated with higher fasted insulin
(P = 0.010), AUCinsulin (P = 0.001), insulinogenic index
(P = 0.008) and lower HOMA-IS index (P < 0.001).
Similar significant associations were found for white
matter. Thus, while higher glucose was associated with
macro-structural damage, impaired insulin action was
associated more strongly with reduced micro-structural
brain parenchymal homogeneity. These findings offer
some insight into the association between different pa-
rameters of glucose metabolism (impairment of which is
characteristic of diabetes mellitus) and brain aging.
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Introduction
The rising prevalence of type 2 diabetes and neurode-
generative disease over the past several decades has
made it of critical importance to understand the relation
of glucose and insulin with the aging brain. The preva-
lence of type 2 diabetes steadily increases with age, with
estimates suggesting that more than half of individuals
older than 65 years have either diabetes or pre-diabetes
(Cowie et al. 2006). Diabetes and pre-diabetic states,
characterized by impairments in glucose, insulin and
insulin sensitivity, are known to be risk factors for
cognitive decline, mild cognitive impairment and de-
mentia (Biessels et al. 2006; Cowie et al. 2006). It is also
known that higher glucose levels, in the absence of
(pre-) diabetes, are associated with increased risk of
accelerated cognitive decline (Vagelatos and Eslick
2013) or dementia (Crane et al. 2013) in older persons.
Furthermore, there is a surge of new information
pointing towards high circulating insulin and insulin
resistance as mediators of neurodegenerative brain dis-
eases (de la Monte and Wands 2008; Steen et al. 2005).
It however remains unclear what the association is of
‘normal’ glucose and insulin (glucose and insulin levels
within the population reference range), with macro- and
micro-structural brain changes in older persons without
diabetes.
Existing literature has demonstrated a decrease in
total brain volume in relation to diabetic and pre-
diabetic states in late middle age (Tan et al. 2011).
Besides these macro-structural changes, however,
micro-structural changes may possibly occur in normal
appearing brain tissue in relation to glucose and insulin,
serving as indices of brain pathology. These micro-
structural brain tissue changes, which are beyond the
spatial resolution of the conventional magnetic resonance
imaging (MRI), can be detectedwithmagnetization trans-
fer (MT) imaging (MTI) (Inglese and Ge 2004). MTI can
also detect differences in the degree of tissue destruction
inmacro-structural lesions (cerebral atrophy, white matter
hyper-intensities, lacunar infarcts or cerebral micro-
bleeds in the white matter). MTI is based on the exchange
of magnetization between protons bound to macro-
molecules and protons of free water molecules inside
tissue. The MT ratio (MTR), which reflects the scale of
this exchange, has been shown to decrease in the presence
of brain tissue damage due to pathology or aging
(Benedetti et al. 2006; Sala et al. 2014). MTR is calcu-
lated per voxel with subsequent generation of a histogram
per region of interest, from which mean MTR and MTR
peak height can be determined. The highest peak of each
histogram is the MTR peak height and is defined as the
number of voxels with themost frequentMTR value. The
meanMTR is defined as the average of theMTR value of
all voxels in the region(s) of interest, as depicted in Fig. 1.
The peak height of a MTR histogram represents the
uniformity within the region of interest. Both mean
MTR and peak height reflect different aspects of MTR,
and they may show different sensitivity in detecting
structural changes in the brain. Specifically, MTR peak
height has been suggested to be a relatively specific
quantitative measure of micro-structural brain parenchy-
mal abnormalities, including myelin content and axonal
numbers (Rademacher et al. 1999). A lower brain tissue
MTR peak height indicates loss of homogeneity of brain
tissue (van Buchem and Tofts 2000) and is observed in
brain parenchymal abnormalities that develop with aging
or disease.
The aim of the present study was to investigate the
association between parameters of glucose metabolism
and three indices of brain pathology, namely gray and
white matter parenchymal volumes and atrophy, macro-
scopic brain damage and micro-structural integrity.
Parameters of glucose metabolism were derived from
oral glucose tolerance test (OGTT) (Takeuchi et al.
2000), and included measures of glucose tolerance,
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insulin sensitivity and pancreaticβ-cell secretory capac-
ity. Macro-structural brain parameters were measured
using MRI and included the presence and number of
micro-bleeds, lacunar infarcts and/or volume of white
matter hyper-intensities. Micro-structural parameters in-
cluded quantification of homogeneity of brain paren-
chyma, including axonal and myelin integrity, as mea-
sured using MTI-derived mean MTR and peak height.
Materials and methods
Study population
Subjects were included from the Leiden Longevity
Study (LLS), which was set up to investigate determi-
nants and pathways associated with healthy aging and
longevity, as previously described (Schoenmaker et al.
2006). A total of 421 Caucasian families were included
and regarded as enriched for familial longevity if at least
two long-lived siblings were alive and fulfilled the age
criteria of ≥89 years for males or ≥91 years for females.
Sex-specific age criteria were used due to the higher life
expectancy of females compared to males. No selection
criteria on health or demographic characteristics were
applied. Offspring of these long-lived nonagenarians
were also included, having inherited on average 50 %
of the genetic propensity of their long-lived parent.
Partners of these offspring, with whom they have shared
the same socio-economic and geographical environment
for decades and who are of a similar age, were also
enrolled. In total, 2415 offspring and partners were
included in LLS.
Of the 2415 subjects included in LLS, a random
subset of 370 underwent a MRI scan of the brain, as
had been previously described (Altmann-Schneider
et al. 2012). Of the 370 subjects, 132 non-diabetic
subjects (75 offspring and 57 partners, comprising 49
couples) also underwent OGTT. Therefore, a total of
132 non-diabetic subjects with reliable, complete
OGTT, brain MRI and MTI data were included in this
study. These participants had no known history of de-
mentia, were free of memory complaints, and had never
visited a memory clinic. Furthermore, the participants
underwent three cognitive tests—Stroop Color Word
test (Stroop test), to test for cognitive flexibility and
executive function; Digit Symbol Substitution Test
(DSST), to evaluate attention and processing speed;
and 15-Picture Word Learning Test (15-PLT), to test
for immediate and delayed memory, as had been earlier
described (Stijntjes et al. 2013). For Stroop test, subjects
were asked to read a color name, which was displayed in
a color different from the color that it actually names.
The outcome parameter was the time (seconds) needed
to complete the test; a higher score indicates a worse
performance. For the DSST, the participants had to
match certain digits with letters according to a provided
key. Outcome parameter was the number of correct
digit-symbol combinations within 90 s. For 15-PLT, 15
pictures were successively presented at a rate of 1 per 2 s
after which the subject was asked to recall as many
pictures as possible. This procedure was carried out
Fig. 1 MTR histogram of gray
and white matter showing mean
MTR and MTR peak height.
MTR histograms of both gray
matter (in blue) and white matter
(in red) with trend lines (moving
averages). The MTR peak height,
the highest peak of each
histogram, is defined as the
number of voxels with the most
frequent MTR value. The mean
MTR, shown as the thick vertical
blue line (for gray matter) and red
line (white matter) is defined as
the average of the MTR value of
all voxels in the region(s) of
interest
AGE (2015) 37: 74 Page 3 of 12 74
three times (PLT-1, PLT-2 and PLT-3). After 20 min,
delayed recall was tested. Outcome parameters were the
number of correct pictures after each trial for PLT-
immediate (immediate recall) and after 20 min for
PLT-delayed (delayed recall).
The Medical Ethical Committee of the Leiden
University Medical Centre approved the study and writ-
ten informed consent was obtained from all participants.
OGTT-derived parameters of glucose metabolism
In the morning after an overnight fast of at least 10 h, an
OGTT was performed with a 75-g glucose load per
300 mL of water. Venous blood samples were with-
drawn at 0, 30, 60 and 120 min after oral ingestion of
the glucose load. Parameters derived from the OGTT
included fasted glucose and area under the curve (AUC)
for glucose (AUCglucose), which are measures of glucose
tolerance; fasted insulin, AUCinsulin and HOMA-IS,
which are measures of insulin action and sensitivity
(Matthews et al. 1985); and insulinogenic index
(Hanson et al. 2000) which is a measure of pancreatic
beta cell secretory capacity. AUC for glucose
(AUCglucose) and insulin (AUCinsulin) were calculated
using the trapezoid formula. The glucose and insulin
curve was first divided into a number of strips of equal
width. Then, the area of the trapezium formed approx-
imated the area of each strip. The sum of these approx-
imations gave the final numerical result of the area under
the glucose (AUCglucose) and insulin (AUCinsulin)
curves, taking into account the measurements them-
selves and the time distance between the measurements
(Pruessner et al. 2003). HOMA-IS was calculated by
dividing 22.5 by the product of the fasting levels of
serum insulin (in mU/L) and glucose (in mmol/L)
(Matthews et al. 1985). Insulogenic index was calculat-
ed by dividing increments of insulin at 30min compared
to fasting values by the corresponding increment at
30 min of glucose levels compared to fasted glucose
values (Hanson et al. 2000).
Biochemical analysis
All serum measurements were performed using fully
automated equipment. For glucose, the Hitachi
Modular P 800 from Roche (Almere, the Netherlands)
was used, with coefficient of variation (CV) less than
5 %. For insulin levels, the Immulite 2500 from DPC
(Los Angeles, CA) was used, with CVof less than 8 %.
Brain MRI study
MRI acquisition
All imaging were performed on a whole body MR
system operating at 3-T field strength (Philips Medical
Systems, Best, The Netherlands). Three-dimensional
(3D) T1-weighted (repetition time 9.7 ms, voxel size
1.17 × 1.17 × 1.4 mm, covering the entire brain,
acquisition time ≈5 min), T2-weighted (repetition time
4200 ms, matrix size 448 × 320, 40 transverse slices
with slice thickness of 3.6 mm, covering the entire
brain) were acquired. Furthermore, fluid-attenuated in-
version recovery (FLAIR, repetition time 11 000 ms,
matrix size 320 × 240, 25 transverse slices with slice
thickness of 5 mm covering the entire brain), T2*-
weighted images (repetition time 45 ms, field of view
250 × 175 × 112 mm) and MTI images were acquired.
MTI was performed with the following parameters:
TR = 100 ms , TE = 11 ms , FA = 9 ° ,
FOV = 224 × 180 × 144 mm, matrix size
224 × 169, and 20 slices with a 7-mm thickness.
Image processing and analysis
Using the Functional MRI of the Brain (FMIRB)
Software Library (FSL) tools, the various analyti-
cal techniques and tools that were used for pro-
cessing and analysis of the MRI scans are de-
scribed below.
Brain volumes
Whole brain, gray matter and white matter volumes
were calculated using the FSL-tool Structural Image
Evaluation, using Normalization, of Atrophy
(SIENAX) (Smith 2002). SIENAX extracted brain and
skull images from the single whole-head input data
(Jenkinson et al. 2002). Thereafter, tissue-type segmen-
tation with partial volume estimation was performed
using FMRIB’s automated segmentation tool (FAST),
and total volume of brain tissue, including separate
estimates of volumes of gray matter and white matter,
was obtained. (Zhang et al. 2001). Additionally, hippo-
campal volume was calculated using the FMRIB’s
Integration Registration and Segmentation Tool
(FIRST), as has been previously described (Altmann-
Schneider et al. 2012).
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Brain atrophy
Atrophy was defined as the difference between intracra-
nial and brain volume divided by intracranial volume
multiplied by hundred percent. Using FSL, an estimate
for the total intracranial volumewas obtained by linearly
aligning each subject’s brain to the MNI152 space and
computing the inverse of the determinant of the affine
matrix.
White matter hyper-intensities, lacunar infarcts
and cerebral micro-bleeds
Medical Image Process ing, Analys is , and
Visualization (MIPAV) software was used to visu-
alize the MRI scans. WMHs and lacunar infarcts
were evaluated using FLAIR, T2-weighted and 3-
D T1-weighted images. Analysis was done blinded
to age, sex and subject identity.
White matter hyper-intensities (WMHs) were de-
fined as areas within the cerebral white matter with
increased signal intensity on both FLAIR and T2-
weighted images, without mass effect (i.e. the increased
signal intensities were not secondary to pushing or
displacing by surrounding tissue). Measurement of the
WMH volume was carried out using the automated
method, whereby 3DT1-weighted images were skull
stripped (Smith et al. 2002) and the FLAIR and 3DT1
image were co-registered in order to create a brain-
extracted FLAIR image (Jenkinson et al. 2002). This
brain-extracted FLAIR image was subsequently affine
registered to MNI152 standard space using the
FMRIB’s Linear Image Registration Tool. A conserva-
tive MNI152 standard space white matter mask was
used to extract the white matter from the FLAIR image.
Finally, after excluding the cerebellum and brainstem, a
threshold was set to identify which white matter voxels
were hyper-intense, followed by manually checking and
editing for quality control.
Lacunar infarcts were defined as parenchymal
defects within the cerebral white matter not ex-
tending into the cortical gray matter, with signal
intensity centrally corresponding to that of cerebral
spinal fluid on all three imaging sequences,
surrounded by a rim of increased signal intensity
on FLAIR (Longstreth et al. 1998). Lacunar infarct
diameter was defined to be >2 mm. To distinguish
lacunar infarcts from normal dilated perivascular
spaces (Virchow-Robin-Spaces), hyper-intensities
within the lower one third of the corpus striatum
of the basal ganglia and a diameter of <2 mm
were excluded (Bokura et al. 1998).
Cerebral micro-bleeds (CMBs) were defined as
round focal areas of signal void on T2-weighted images,
which increased in size on T2*-weighted images
(blooming effect) (Greenberg et al. 2009). Thus,
CMBs can be distinguished from look-alikes such as
vascular flow voids. Symmetric hypo-intensities in the
basal ganglia were disregarded, as they are likely to
represent calcifications or non-hemorrhagic iron depo-
sition (Greenberg et al. 2009).
MTI data processing
The individual 3DT1 images were skull stripped
using BET (brain extracting tool) and segmented
using FAST (FMRIB’s automated segmentation
tool), resulting in individual brain masks for white
matter and cortical gray matter. Subsequently, non-
saturated (M0) and saturated images were registered
to the T1 image, using FMRIB’s linear image regis-
tration tool (FLIRT). Registration matrices from the
previous step were used to co-register the non-
saturated M0 images and the individual brain masks
for gray and white matter to create separate gray and
white matter MTR maps. To correct for possible
partial volume effects, an eroded mask of these
segmentations was created by removing one voxel
in plane for both volumes of interest (VOIs).
Individual MTR maps were calculated voxel by
voxel following the equation MTR = (M0 − M1) /
M0 and MTR histograms were generated for both
VOIs. Mean MTR, MTR peak height, corrected for
the size of the VOI, and MTR peak location were
calculated from each MTR histogram. The mean of
the MTR value of all voxels in the histogram is the
mean MTR, and the highest peak of each histogram
is the MTR peak height, as depicted in Fig. 1.
For the voxel-based analysis of gray matter, the MTR
GM maps were aligned to MNI standard space using
non-linear transformation (Andersson et al. 2007) and
averaged to create a reference template forMTR images.
Then, all individual gray matter MTR maps were non-
linearly registered to this template, divided by the
Jacobian of the warp field and smoothed with an isotro-
pic Gaussian kernel with a sigma of 3 mm (Cosottini
et al. 2011).
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Statistical analyses
Analyses were conducted in a three-step approach. First,
we assessed the association between OGTT-derived pa-
rameters of glucose metabolism and brain atrophy.
Secondly, we investigated the association between
OGTT-derived parameters and macroscopic brain dam-
age (cerebral micro-bleeds, lacunar infarcts and volume
of white matter hyper-intensities). Thirdly, we assessed
the relation between OGTT-derived parameters and
brain micro-structural integrity.
Data analysis was done using Statistical Package for
Social Sciences (SPSS) software for windows (version
20.0). Unless otherwise stated, data are presented as
mean with standard deviation (SD). Distributions of
continuous variables were examined for normality, log-
arithmically transformed when appropriate and used in
calculations. Serum insulin levels (fasted and
AUCinsulin) and HOMA-IS were logarithmically trans-
formed with resultant normalization of their skewed
distribution. Geometric means are reported for trans-
formed variables. Linear regression model was used to
investigate the associations between OGTT-derived pa-
rameters, gray and white matter atrophy and MR brain
tissue markers for micro-structural integrity. The initial
analyses were adjusted for age, sex and descent (Leiden
longevity offspring/partner status). Extended models
further included smoking status, BMI, use of anti-
hypertensive and use of lipid-lowering agents.
Statistical significance was defined as P < 0.05.
For MRI data, voxel-wise analysis statistics was car-
ried out with FSL randomize using permutation-based
non-parametric testing (5000 permutations). Threshold-
free cluster enhancement was used to optimize sensitiv-
ity to different shapes and sizes of MRI signals, to
separate true signals from noise (Smith and Nichols
2009), with a significance level set at P < 0.05, con-
trolled for family wise error rate. Age and gender of
participants were inserted as covariates in the model.
Results
Characteristics of the study subjects are summarized in
Table 1. The mean age of the subjects was 66 years (SD
6.6); 62 (47 %) were males and 70 (53 %) were females.
Medical history showed that 29 % had hypertension,
22 % used anti-hypertensive medication(s), 14 % used
lipid-lowering drugs, 1 % had had a previous CVA and
1 % had had a previous myocardial infarction. All
OGTT-derived parameters were within normal reference
range. Table 1 also shows the mean gray and white
matter volumes and atrophy, and the mean MTI param-
eters of the subjects. The mean time needed to complete
the Stroop test was 48 s, while there was an average of
47 correct answers for the DSST. Mean number of
correct pictures for 15-PLT immediate and delayed re-
call was 10 and 11, respectively (Table 1). From the
cross-sectional data, no significant correlation was
found between the cognitive tests, which are a measure
of functional brain integrity, andMTRpeak height, which
is a measure of micro-structural brain parenchymal tissue
homogeneity, nor with white matter hyper-intensities,
lacunar infarcts or cerebral micro-bleeds (data not
shown).
Parameters of glucose metabolism and atrophy
We assessed the association of OGTT-derived parame-
ters of glucose metabolism with gray matter, white
matter and hippocampal atrophy. Parameters of glucose
metabolism included measures of glucose tolerance
(fasted glucose and area under the glucose curve
(AUCglucose)), measures of insulin sensitivity (fasted
insulin, area under the insulin curve (AUCinsulin) and
homeostatic model assessment of insulin sensitivity
(HOMA-IS) index) and a measure of pancreatic β-
cells secretory capacity (insulinogenic index). As shown
in Table 2, higher fasted glucose was associated with
white matter atrophy (β = −0.189, P = 0.028). No
association was found between any of the OGTT-
derived parameters and hippocampal atrophy (data not
shown) or gray matter atrophy (Table 2).
Parameters of glucose metabolism and macroscopic
brain damage
The associations of measures of glucose tolerance, mea-
sures of insulin action and insulinogenic index with mac-
roscopic brain damage were investigated (data not shown).
Indices of macroscopic brain damage included the pres-
ence and number of micro-bleeds, lacunar infarcts and/or
volume of the white matter hyper-intensities, as measured
using MRI. Fasted glucose was inversely associated with
number of cerebral micro-bleeds (β = −0.214, R2 = 0.053,
P = 0.045). None of the other OGTT-derived parameters
(AUCglucose, fasted insulin AUCinsulin, HOMA-IS or
insulinogenic index) were significantly associated with
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Table 1 Description of study subjects
Characteristics N = 132
Demographics
Men, n (%) 62 (47)
Age in years 66 (6.6)
BMI in kg/m2 26 (4)
Current smoking, n (%) 11 (8)
Medical history
Myocardial infarct, n (%) 1 (0.8)
Hypertension, n (%) 29 (22)
Use of anti-hypertensive medications, n (%) 37 (28)
CVA, n (%) 1 (0.8)
Use of lipid-lowering medications, n (%) 14 (11)
OGTT-derived characteristics
Fasted glucose in mmol/L 5.1 (0.6)
AUC glucose in mmol/L 14 (4)
Fasted insulin in pmol/L, median (25th, 75th percentile) 42 (28, 73)
AUC insulin, median (25th, 75th percentile) 94 (64, 139)
HOMA-IS index, median (25th, 75th percentile) −1.5 (−0.7, −2.4)
Insulinogenic index, median (25th, 75th percentile) 13 (7, 20)
HbA1c in % (mmol/mol) 5.2 (33)
Cognitive tests results
Digit Symbol Substitution Test, correct answers 46.5 (10)
Stroop test, seconds 48 (13)
15-PLTi, correct pictures 10 (2)
15-PLTd, correct pictures 11 (2)
Brain volumes in cm3
White matter 541 (57)
Gray matter 542 (36)
Brain atrophy in %
Whole brain 24.1 (3.4)
White matter 2.8 (5.4)
Gray matter 20.9 (4.5)
Mean magnetization transfer ratio
White matter 0.385 (0.010)
Gray matter 0.333 (0.097)
Peak height, pixel count × 103
White matter 117 (24)
Gray matter 74 (12)
Macro-structural characteristics
White matter hyper-intensities, n (%) 119 (90)
Lacunar infarcts, n (%) 5 (3.8)
Cerebral micro-bleeds, n (%) 14 (11)
Values are means (SD, standard deviation), unless otherwise stated. Age refers to age at MRI examination. BMI body mass index, CVA
cerebrovascular accident, OGTT oral glucose tolerance test, AUC area under the curve, HOMA-IS homeostatic model assessment of insulin
sensitivity, 15-PLTi 15-Picture Learning Test-immediate recall, 15-PLTd 15-Picture Learning Test-delayed recall
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indices of macroscopic brain damage. Repetition of the
analyses while adjusting for age, gender, descent, smoking
status, use of anti-hypertensive and use of lipid-lowering
agents did not materially change the results.
Parameters of glucose metabolism and brain
micro-structure
Table 3 shows the association of OGTT-derived glucose
and insulin parameters with micro-structural gray and
white matter parenchymal integrity, measured via
magnetization transfer imaging, and expressed in mean
MTR and MTR peak height. A lower brain tissue mean
MTR or peak height indicates loss of homogeneity of
brain tissue or tissue damage. In the gray matter, param-
eters of reduced insulin action, namely, higher fasted
insulin (β = −0.213, P = 0.010), AUCinsulin (β = −0.276,
P = 0.001), insulinogenic index (β = −0.289, P < 0.001)
and decreased HOMA-IS (β = 0.220, P = 0.008), were
significantly associated with lower gray matter MTR
peak height. Similarly, higher AUCinsulin was associated
with reduced mean gray matter MTR. Similar trends
Table 2 Association of gray and white matter atrophy with parameters of glucose metabolism
Atrophy
Gray matter White matter
Beta P value R2 Beta P value R2
Fasted glucose 0.007 0.924 0.336 −0.189 0.028* 0.191
AUC glucose −0.042 0.586 0.337 −0.148 0.084 0.179
Fasted insulin 0.002 0.983 0.336 −0.082 0.325 0.166
AUC insulin −0.059 0.420 0.339 −0.076 0.361 0.165
HOMA-IS index −0.003 0.968 0.336 0.105 0.213 0.170
Insulinogenic Index −0.076 0.302 0.342 0.087 0.292 0.167
Atrophy is defined as the difference between intracranial and brain volumes divided by intracranial volume multiplied by hundred percent.
All insulin values were log-transformed. Associations are expressed as standardized Beta with corresponding P-values. Results are from
linear regression analysis corrected for age, gender and offspring- partner status
AUC Area under the curve, HOMA-IS Homeostatic model assessment of insulin sensitivity
*p<0.05
Table 3 Association of magnetization transfer imaging (MTI)-derived integrity of gray and white matter micro-structure with parameters of
glucose metabolism
Gray matter White matter
Mean MTR Peak height Mean MTR Peak height
Beta P value R2 Beta P value R2 Beta P value R2 Beta P value R2
Fasted glucose −0.124 0.166 0.159 −0.150 0.084 0.216 0.058 0.528 0.106 −0.050 0.572 0.181
AUC glucose −0.165 0.063 0.170 −0.113 0.191 0.207 −0.031 0.737 0.103 −0.133 0.127 0.194
Fasted insulin −0.068 0.432 0.150 −0.213 0.010* 0.239 0.110 0.213 0.114 −0.189 0.024* 0.213
AUC insulin −0.181 0.033* 0.177 −0.276 0.001* 0.269 −0.033 0.709 0.104 −0.264 0.001* 0.246
HOMA-IS index 0.081 0.351 0.152 0.220 0.008* 0.241 −0.110 0.217 0.114 0.184 0.030* 0.210
Insulinogenic index −0.151 0.075 0.168 −0.289 <0.001* 0.277 0.018 0.833 0.103 −0.210 0.011* 0.221
All insulin values were log transformed. The standardized beta and corresponding P values are shown for analysis using individual brain
volume corrected for head size. Results are from linear regression analysis corrected for age, gender and offspring partner status
MTR magnetization transfer ratio, AUC area under the curve, HOMA-IS homeostatic model assessment of insulin sensitivity
*p<0.05
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were seen between other OGTT-derived parameters and
mean MTR, but these did not reach statistical
significance.
In the white matter, increased fasted insulin
(β = −0.189, P = 0.024), AUCinsulin (β = −0.264,
P = 0.001), insulinogenic index (β = −0.210,
P = 0.011) and decreased HOMA-IS (β = 0.184,
P = 0.030) were significantly associated with decreased
white matter MTR peak height. These associations did
not materially change after adjustment for age, gender,
descent, smoking status, BMI, use of anti-hypertensive
and use of lipid-lowering agents.
For visualization of the relations between reduced
insulin action and brain micro-structure, scatterplots
were made as well as voxel-based analysis, using area
under the insulin curve (AUCinsulin). Figure 2 shows the
inverse relation of AUCinsulin with gray matter peak
height (Fig. 2a) and white matter peak height (Fig. 2b).
Furthermore, via voxel-based morphometric analysis, the
associations between cortical gray matter MTR with
AUCinsulin are projected on T1-weighted images, as shown
in Fig. 3, where the corresponding decrease in cortical gray
matter MTR with increasing AUCinsulin can be seen.
Sensitivity analyses
To determine whether high ‘normal’ glucose levels, i. e.
glucose levels in the upper normal range (5.7–6.8 mmol/l),
modulated the observed effects of glucose, sub-analyses
were also conducted with lower fasting glucose levels
(<5.6 mmol/l). The findings of these were essentially
similar to the results presented above.
Conclusions and discussion
We report two main findings. The first is that subclinical
variation in fasted glucose was associated with white
matter atrophy. Secondly, in the absence of type 2 dia-
betes, higher insulin and reduced peripheral insulin ac-
tion and sensitivity were associated with reduced micro-
structural brain integrity in older adults without
diabetes.
The role of metabolic derangement associated with
(pre-) diabetic states in the decline in brain structure and
function is an area of active investigation. Previous
studies have shown relations between glucose levels
(ranging from high normal to diabetic levels), with
decreasing total brain volumes and cognition (Cui
et al. 2014; Espeland et al. 2013; Mortby et al. 2013;
Samaras et al. 2014). Associations between impairments
in glucose regulation and smaller total brain volumes
were found in a large cohort of middle-aged diabetic and
non-diabetic subjects of the Framingham study, where
inverse correlations were found between total cerebral
brain volumes and HbA1c, HOMA-IR and fasted
Fig. 2 Relation between the area under the insulin curve and
MTR peak height in gray and white matter. Scatterplots showing
the inverse relation between area under the insulin curve
(AUCinsulin) and a gray matter and b white matter MTR peak
height. Lines of best fit were derived from bivariate Pearson’s
correlations
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insulin levels (Tan et al. 2011). In harmony with these
studies, we found a significant association between in-
dices of impairments in glucose regulation (fasted glu-
cose, fasted insulin, AUCinsulin and HOMA-IS) and gray
and white matter micro-structure. Of note, there is an
inverse relation between homeostatic model assessment
of insulin sensitivity (HOMA-IS) and homeostatic mod-
el assessment of insulin resistance (HOMA-IR). The
white matter atrophy observed in relation to fasted glu-
cose in our study is consistent with previous research
demonstrating high-‘normal’ blood glucose levels being
associated with lower gray and white matter regional
volumes (Mortby et al. 2013). Our findings thus suggest
that the effect of plasma glucose on cerebral structural
integrity in older people is not restricted to the upper
normal range.
We describe here for the first time that in-
creased fasted insulin and AUCinsulin and decreased
HOMA-IS and insulinogenic index were significantly
associated with decreased MTR histogram peak-
height for both gray and white matter, indicating
loss of homogeneity of brain tissue or tissue
damage. Similar trends were found for mean
MTR, but these were not statistically significant.
Although mean MTR and histogram peak-height
of MTR are both MTR measures, they reflect different
aspects of MTR and may show considerable difference
in sensitivity with respect to demonstrating variations in
structural brain integrity (Benedetti et al. 2006; Ropele
et al. 2010; van den Bogaard et al. 2012; Yamamoto
et al. 2006). Peak heights of MTR histograms are a
sensitive measure of micro-structural brain parenchymal
abnormalities, loss of which has been associated with
both aging and metabolic syndrome (Benedetti et al.
2006; Sala et al. 2014). Of note, previous population-
based, longitudinal studies have suggested insulin and
insulin resistance as being a link between diabetes and
neurodegenerative diseases (Ronnemaa et al. 2008;
Schrijvers et al. 2010). Interestingly, our findings
showed lower MTR histogram peak heights in
gray and white matter in relation with higher
fasted insulin and decreasing sensitivity to insulin. We
found an inverse association between fasted glucose and
cerebral micro-bleeds, which was of borderline
Fig. 3 Voxel-based analysis of relation between cortical gray
matter magnetization transfer ratio and insulin. Color scaling
legend: color (red-orange) represents voxels that are statistically
significant for lower gray matter MTR in association with higher
AUC insulin (area under the insulin curve). Results are from
voxel-based morphometric (VBM) analysis of cortical gray matter
MTI magnetization transfer ratio (MTR). Results are projected on
the MNI152 space T1-weighted image provided by FSL. Statisti-
cal analysis was adjusted for sex, age and offspring-partner status.
Threshold-free cluster enhancement was applied with a signifi-
cance level set at P < 0.05, corrected for family wise error rate
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significance (P = 0.045). However, since the R2 was
very low (R2 = 0.053), we could not exclude the possi-
bility that this could have been a chance finding. No
other significant association was found between indices
of disturbances in glucose or insulin parameters and
macro-structural brain pathology (white matter hyper-
intensities, lacunar infarcts, cerebral micro-bleeds).
Taken together, these findings suggest that metabol-
ically related brain structural abnormalities are observ-
able at a microscopic level, even in the presence of
glucose and insulin levels that are considered normal
by present standards. An inverse association was found
between OGTT-derived insulin parameters (fasted insu-
lin, AUCinsulin, HOMA-IS and insulinogenic index) and
gray and white matter micro-structural integrity. This
suggests a link between reduced insulin action (evi-
denced by higher insulin and reduced peripheral insulin
sensitivity) and loss of homogeneity of brain tissue
(reflecting parenchymal abnormalities), even in older
adults without diabetes. One possible mechanism that
may underpin these findings is that with aging, the
ability to maintain the delicate balance between the
various gluco-regulatory mechanisms declines, leading
to deleterious micro-structural changes in neuronal and
thus brain tissue integrity. Such micro-structural brain
changes may exist even without the appearance of overt
macro-structural changes that are associated with clini-
cally significant metabolic disease.
It is a limitation of this study that we only examined
cross-sectional associations and did not examine the
association of changes of these measures over time.
Thus, our findings are descriptive, and no causal infer-
ence can be made. A strength of this study is that, in
addition to using conventional MRI, magnetization
transfer imaging (MTI) was used, which is an advanced
MRI technique that has the discriminatory power to
detect in vivo micro-structural brain changes and quan-
titatively measure brain parenchyma abnormalities that
are beyond the spatial resolution of conventional MRI.
In conclusion, using sensitive MRI techniques, we
observed that subclinical differences in glucose and
insulin metabolism were associated with macro- and
micro-structural brain changes in older adults, and these
were detectable even with glucose and insulin levels
within population reference ranges. These findings pos-
sibly offer more insight into the association between
different parameters of glucose metabolism and brain
aging. Sufficiently powered follow-up studies are need-
ed to evaluate cause or consequence in the relation
between parameters of glucose metabolism and brain
integrity.
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